Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/14135| Title: | Pharmacogenetics : where do we stand? |
| Authors: | Fenech, Anthony G. Grech, Godfrey |
| Keywords: | Pharmacogenetics Pharmacogenomics Personalized medicine |
| Issue Date: | 2011 |
| Publisher: | Malta College of Pharmacy Practice |
| Citation: | Fenech, A. G., & Grech, G. (2011). Pharmacogenetics : where do we stand? Journal of the Malta College of Pharmacy Practice, 17, 25-33. |
| Abstract: | “Our drugs do not work on most patients.” Such did Allen Roses, then worldwide vice-president of genetics at GlaxoSmithKline, greet his audience, during a scientific meeting in London in 2003.1 Nearly a decade has passed since then, and significant strides towards the development of genotype-guided prescribing have been made. Pharmacogenetics and pharmacogenomics are now an established area of pharmacology specialization, and they hold the promise of the key to personalized medicine, leading to safer and more effective patientfocussed therapeutic outcomes. |
| URI: | https://www.um.edu.mt/library/oar//handle/123456789/14135 |
| Appears in Collections: | JMCPP, Issue 17 JMCPP, Issue 17 |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 2011-17-5.pdf | Pharmacogenetics : where do we stand? | 102.79 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.